Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients-Reference-Cited by-同舟云学术

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients

Published:2008-05 Issue:5 Volume:14 Page:591-594
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Horwitz Mitchell E.,Morris Ashley,Gasparetto Cristina,Sullivan Keith,Long Gwynn,Chute John,Rizzieri David,McPherson Jackie,Chao Nelson

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference14 articles.

1. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS;de Lima;Blood,2004

2. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia;Laughlin;N Engl J Med,2004

3. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy;Barker;Blood,2005

4. Double unrelated reduced-intensity umbilical cord blood transplantation in adults;Ballen;Biol Blood Marrow Transplant,2007

5. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease;Brunstein;Blood,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score;Blood Advances;2024-03-13

2. Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study;American Journal of Hematology;2024-01-02

3. Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation;Transplantation and Cellular Therapy;2023-05

4. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil;Annals of Hematology;2022-10-05

5. Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases;Cell Transplantation;2022-01